endosergЭндокринная хирургияEndocrine Surgery2306-35132310-3965Типография «Печатных дел Мастер»10.14341/serg2015432-38endoserg-7809Research ArticleКлинический случайClinical CaseДифференцированный рак щитовидной железы, выявленный во время беременности. Опыт веденияWell-differentiated thyroid cancer disclosed during pregnancy. Management experienceИльинАлексей АмуровичIlyinA. A.

в.н.с.

MD, PhD

ilyin@mrrc.obninsk.ruhttps://orcid.org/0000-0002-7721-634XРумянцевПавел ОлеговичRumyantsevP. O.

доктор медицинских наук, заместитель директора

MD, PhD

rumyantsev.pavel@endocrincentr.ruДербуговДмитрий НиколаевичDerbugovD. N.

Врач

MD

derbugov@mrrc.obninsk.ruСеминДмитрий ЮрьевичSeminD. N.

врач

MD

siomin@mrrc.obninsk.ruСеверскаяНаталья ВикторовнаSeverskayaN. V.

зав. отделением

MD, PhD

severskn@mrrc.obninsk.ruИсаевПавел АнатольевичIsaevP. A.

в.н.с.

MD, PhD

isaev@mrrc.obninsk.ruВасильковСергей ВасильевичVasilkovS. V.

врач

MD

vasilkov@mrrc.obninsk.ruМедведевВиктор СтепановичMedvedevV. S.

Зав. отделением

MD, PhD, Professor

medvedev@mrrc.obninsk.ruПолькинВячеслав ВикторовичPolkinV. V.

в.н.с.

MD, PhD

polkin@mrrc.obninsk.ruМедицинский радиологический научный центр им. А.Ф. Цыба – филиал ФГБУ “Национальный медицинский исследовательский радиологический центр”РоссияTsyb Medical Radiological Research Centre, National Medical Research Radiological CentreRussian FederationФГБУ "Эндокринологический научный центр" Минздрава РоссииРоссияEndocrinology Research CentreRussian FederationМедицинский радиологический научный центр им. А.Ф. Цыба - филиал ФГБУ «НМИРЦ» Минздрава РоссииРоссияTsyb Medical Radiological Research Centre, National Medical Research Radiological CentreRussian Federation201530122015943238Copyright © Ильин А.А., Румянцев П.О., Дербугов Д.Н., Семин Д.Ю., Северская Н.В., Исаев П.А., Васильков С.В., Медведев В.С., Полькин В.В., 20152015Ильин А.А., Румянцев П.О., Дербугов Д.Н., Семин Д.Ю., Северская Н.В., Исаев П.А., Васильков С.В., Медведев В.С., Полькин В.В.Ilyin A.A., Rumyantsev P.O., Derbugov D.N., Semin D.N., Severskaya N.V., Isaev P.A., Vasilkov S.V., Medvedev V.S., Polkin V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.surg-endojournals.ru/jour/article/view/7809

Рак щитовидной железы (РЩЖ) является вторым по частоте встречаемости злокачественным новообразованием, выявляемым во время беременности. Обнаружение РЩЖ у беременных вызывает много вопросов у эндокринологов, онкологов и акушеров-гинекологов по тактике ведения этих пациентов. В настоящей статье проанализированы результаты лечения 15 женщин с дифференцированным РЩЖ, выявленным во время беременности. Наш опыт ведения этих больных свидетельствует, что тактика с отсрочкой хирургического вмешательства после родоразрешения, при отсутствии признаков прогрессирования местнораспространенного опухолевого процесса, не приводит к ухудшению ближайших и отдаленных результатов лечения. 

Thyroid cancer have the second place as malignancy detectable during pregnancy. Disclose of thyroid cancer during pregnancy raises many questions among endocrinologists, oncologists and obstetricians. Our aim was to analyze the results of delayed treatment in 15 women with differentiated thyroid cancer diagnosed during pregnancy. Our experience shows that in absence of progression of locally advanced differentiated thyroid cancer during pregnancy the observation tactics with deferred surgical treatment after delivery is reasonable, which is not worsening early and late results of delayed treatment.

дифференцированный рак щитовидной железыбеременностьхирургическое лечениеwell-differentiated thyroid cancerpregnancysurgical treatmentReferencesSmith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189(4):1128-1135. doi: 10.1067/S0002-9378(03)00537-4.Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189(4):1128-1135. doi: 10.1067/S0002-9378(03)00537-4.Rosene-Montella K. Medical Management of the Pregnant Patient. A Clinician’s Handbook. New York: Springer; 2015. doi: 10.1007/978-1-4614-1244-1.Rosene-Montella K. Medical Management of the Pregnant Patient. A Clinician’s Handbook. New York: Springer; 2015. doi: 10.1007/978-1-4614-1244-1.Vini L, Hyer S, Pratt B, Harmer C. Management of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol. 1999;140(5):404-406. doi: 10.1530/eje.0.1400404.Vini L, Hyer S, Pratt B, Harmer C. Management of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol. 1999;140(5):404-406. doi: 10.1530/eje.0.1400404.Cabezon CA, Carrizo LC, Costanzo PR. Evolution of differentiated thyroid cancer during pregnancy in a community University Hospital in Buenos Aires, Argentina. Arq Bras Endocrinol Metabol. 2013;57(4):307-311. doi: 10.1590/S0004-27302013000400005.Cabezon CA, Carrizo LC, Costanzo PR. Evolution of differentiated thyroid cancer during pregnancy in a community University Hospital in Buenos Aires, Argentina. Arq Bras Endocrinol Metabol. 2013;57(4):307-311. doi: 10.1590/S0004-27302013000400005.Budak A, Gulhan I, Aldemir OS, et al. Lack of influence of pregnancy on the prognosis of survivors of thyroid cancer. Asian Pac J Cancer Prev. 2013;14(11):6941-6943. doi: 10.7314/APJCP.2013.14.11.6941.Budak A, Gulhan I, Aldemir OS, et al. Lack of influence of pregnancy on the prognosis of survivors of thyroid cancer. Asian Pac J Cancer Prev. 2013;14(11):6941-6943. doi: 10.7314/APJCP.2013.14.11.6941.Messuti I, Corvisieri S, Bardesono F, et al. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features. Eur J Endocrinol. 2014;170(5):659-666. doi: 10.1530/EJE-13-0903.Messuti I, Corvisieri S, Bardesono F, et al. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features. Eur J Endocrinol. 2014;170(5):659-666. doi: 10.1530/EJE-13-0903.Hirsch D, Levy S, Tsvetov G, et al. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid. 2010;20(10):1179-1185. doi: 10.1089/thy.2010.0081.Hirsch D, Levy S, Tsvetov G, et al. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid. 2010;20(10):1179-1185. doi: 10.1089/thy.2010.0081.Zamora-Ros R, Rinaldi S, Biessy C, et al. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study. Int J Cancer. 2015;136(5):1218-1227. doi: 10.1002/ijc.29067.Zamora-Ros R, Rinaldi S, Biessy C, et al. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study. Int J Cancer. 2015;136(5):1218-1227. doi: 10.1002/ijc.29067.Cao Y, Wang Z, Gu J, et al. Reproductive Factors but Not Hormonal Factors Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis. Biomed Res Int. 2015;2015:103515. doi: 10.1155/2015/103515.Cao Y, Wang Z, Gu J, et al. Reproductive Factors but Not Hormonal Factors Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis. Biomed Res Int. 2015;2015:103515. doi: 10.1155/2015/103515.Walshe P, Seaberg RM, Yehuda M, Freeman J. Management of medullary carcinoma of the thyroid during pregnancy in a patient with an intron substitution. J Otolaryngol Head Neck Surg. 2008;37(2):E39-41.Walshe P, Seaberg RM, Yehuda M, Freeman J. Management of medullary carcinoma of the thyroid during pregnancy in a patient with an intron substitution. J Otolaryngol Head Neck Surg. 2008;37(2):E39-41.Sarathi V, Bandgar TR, Menon PS, Shah NS. Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient. Gynecol Endocrinol. 2011;27(8):533-535. doi: 10.3109/09513590.2010.507285.Sarathi V, Bandgar TR, Menon PS, Shah NS. Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient. Gynecol Endocrinol. 2011;27(8):533-535. doi: 10.3109/09513590.2010.507285.Muzannara MA, Tawfeeq N, Nasir M, et al. Vaginal delivery in a patient with pheochromocytoma, medullary thyroid cancer, and primary hyperparathyroidism (multiple endocrine neoplasia type 2A, Sipple's syndrome). Saudi J Anaesth. 2014;8(3):437-439. doi: 10.4103/1658-354X.136652.Muzannara MA, Tawfeeq N, Nasir M, et al. Vaginal delivery in a patient with pheochromocytoma, medullary thyroid cancer, and primary hyperparathyroidism (multiple endocrine neoplasia type 2A, Sipple's syndrome). Saudi J Anaesth. 2014;8(3):437-439. doi: 10.4103/1658-354X.136652.Vannucchi G, Perrino M, Rossi S, et al. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol. 2010;162(1):145-151. doi: 10.1530/EJE-09-0761.Vannucchi G, Perrino M, Rossi S, et al. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol. 2010;162(1):145-151. doi: 10.1530/EJE-09-0761.Shindo H, Amino N, Ito Y, et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid. 2014;24(5):840-844. doi: 10.1089/thy.2013.0527.Shindo H, Amino N, Ito Y, et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid. 2014;24(5):840-844. doi: 10.1089/thy.2013.0527.Duntas LH. Clinical comments related to medullary thyroid cancer diagnosis and management. Thyroid Res. 2013;6 Suppl 1:S6. doi: 10.1186/1756-6614-6-S1-S6.Duntas LH. Clinical comments related to medullary thyroid cancer diagnosis and management. Thyroid Res. 2013;6 Suppl 1:S6. doi: 10.1186/1756-6614-6-S1-S6.

The authors declare that there are no conflicts of interest present.